Skip to main content
Fig. 2 | Journal of Neuroinflammation

Fig. 2

From: JNK signalling mediates aspects of maternal immune activation: importance of maternal genotype in relation to schizophrenia risk

Fig. 2

Chemokine levels in embryonic brain as measured by Luminex Multiplex panel or ELISA (CCL5 only). CCL2 levels were unaffected by genotype or treatment (a). Overall, CCL5 (b) and CXCL10 (c) levels were significantly increased in the brains of embryos whose mother had been exposed to polyI:C, compared to brain levels in embryos whose mother had received saline. Results shown are mean ± SEM. Data analysed by three-way ANOVA with embryonic genotype, maternal genotype, and treatment as factors. F values are provided in Additional file 1. N = 4/group. ***p < 0.001 effect of treatment (ANOVA); ##p < 0.01 as shown; *p < 0.05, **p < 0.01 vs WT dam, the same treatment and embryo genotype (post-hoc Fisher’s test)

Back to article page